INSERM U1183 "Cellules souches, plasticité cellulaire, médecine régénératrice et immunothérapies"
  • Accueil
  • Equipes
    • Equipe 1 >
      • Daniele Noel
      • Farida Djouad
      • Christian Jorgensen
      • Martine Daujat
      • Carole Crozet
    • Equipe 2 >
      • Jean-Marc Lemaitre
      • John De Vos
      • Therese Commes
    • Equipe 3 >
      • Isabelle Touitou-David Geneviève
      • Pascale Louis-Plence
      • Florence Apparailly
      • Mireia Pelegrin
    • Equipe 4 >
      • Martin Villalba
      • Javier Hernandez
  • Laboratoires hospitaliers - Plateformes
  • Unité clinique
  • Enseignement
  • Actualités
  • Acces & Contact
  • Annuaire
The Institute for Regenerative Medicine and Biotherapy in Montpellier seeks new group leaders in stem cell biology or Immunology.
 
The Institute for Regenerative Medicine and Biotherapy (IRMB) associates the University Hospital of Montpellier (CHU Montpellier), the INSERM and the University Montpellier (UM). It is composed of 4 research groups, and gathers 150 scientists & engineers with scientific & medical expertise on regenerative medicine, stem cells biology as well as immunology. The objectives of IRMB are to increase the knowledge of stem cell biology, interactions between stem cells and immune cells, stem cell niches and homing, as well as the role of epigenetics mechanisms in chronic and age-related diseases. These researches include both basic biological aspects and innovative applications of regenerative therapy. IRMB combines on a single site the INSERM unit U1183, hospital laboratories, private companies gathered around common technical platforms and two national infrastructures in health biology dedicated to stem cells. The IRMB is a leading research INSERM institute in stem cell research and immunology in the south of France. IRMB members closely interact with other Institutes belonging to the biomedical health cluster “Pole Rabelais”.

​
Research at the institute covers fundamental and translational aspects of biology, with focus on:
  • Cell reprogrammation, ageing, epigenetics
  • Mesenchymal stem cell biology
  • Innovative Immunotherapy
  • Cell therapy Transposition to the clinic
  • Bioinformatics and molecular modelling
IRMB is recruiting new junior/senior group leaders (for ex ATIP/AVENIR laureate) to start January 2017. Successful candidates will be expected to establish a world-class research program reinforcing these topics, in an interactive and supportive environment. All projects with the potential to synergize with IRMB topics will be considered, including interdisciplinary projects. New group leaders will receive laboratory space (including 2 offices, conventional lab and L2) and access to multiple technological platforms, including cutting-edge imaging facility hosted by IRMB. The Institute benefits from state-of-the-art platforms dedicated to imaging, proteomics, animal facilities (zebrafishes, and transgenic mice), deep sequencing and transcriptomics, FACS sorting, and confoncal imaging. IRMB is both part of the national ECELLfrance (National infrastructure) dedicated to stem cell based regenerative medicine applications and to the INGESTEM (National infrastructure) for iPSC based clinical developments as well as participant to the French Laboratories of Excellence programme (Labex Epigenmed).
Montpellier is a dynamic and attractive Mediterranean city in an exceptional research environment. It is home to many high quality research institutes, a vibrant student population and one of the world’s oldest medical schools. If interested, the applicant should send CV, letter of motivation and summary of scientific project in max. 2 pages before 30 September 2016, for a final decision 20 December 2016.
 

Contact : Pr Christian JORGENSEN, @mail : christian.jorgensen@inserm.fr, Phone : 04.67.33.06.88.

Accueil

Equipes

Plateformes

Accès & Contact

Annuaire